FREE Case Review (866) 588-0600

Victoza Pancreatic Cancer

A 2011 study published in the medical journal Gastroenterology found that diabetics using drugs from the same incretin mimetic class as Victoza had close to a threefold increased risk of developing pancreatic cancer.

The law offices of Schmidt & Clark, LLP, are currently investigating cases of pancreatic cancer in individuals who took the type 2 diabetes drug Victoza (generic: liraglutide). A 2011 study published in the medical journal Gastroenterology found that diabetics using drugs from the same incretin mimetic class as Victoza had close to a threefold increased risk of developing pancreatic cancer compared to individuals who took other types of drugs.

Free Confidential Lawsuit Evaluation: If you or a loved one has been diagnosed with pancreatic cancer after taking Victoza, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Update: LEADER Trial Finds Increased Risk of Pancreatic Cancer with Victoza

June 17, 2016 – A study published this month in the New England Journal of Medicine (NEJM) found a potential increased risk of pancreatic cancer in patients treated with Victoza. Specifically, pancreatic cancer occurred in 13 Victoza users patients compared to 5 patients treated with placebo (13 vs 5, HR 2.60, 95% CI 0.93, 7.28 p = 0.06).

Victoza Overview

Manufactured and marketed by Novo Nordisk, Victoza was approved by the U.S. Food & Drug Administration (FDA) in 2010. The drug is a once-daily injection that provides glucagon-like peptide-1 (GLP-1) therapy. GLP-1 is a hormone that stimulates the production of insulin, which is necessary to help metabolize sugar in the human body. GLP-1 therapies such as Victoza are designed to work by imitating the activity of this hormone. However, recent studies have determined that Victoza may increase the risk of serious complications such as pancreatic cancer.

How Can Victoza Cause Pancreatic Cancer?

Over the past several years, there has been a growing concern over incretin mimetic diabetes drugs like Victoza and pancreatic cancer, a life-threatening disease that is not often detected until its later stages. The 2011 Gastroenterology study found that Byetta (another incretin mimetic similar to Victoza) was linked to a nearly 3-fold increased risk of pancreatic cancer. Peter Butler, one of the authors of the study, has called for additional studies to examine the association between GLP-1 therapies and pancreatic cancer.

“The data we have so far makes the question sufficiently robust that it has to be answered,” Butler stated. “Hopefully this debate will raise the awareness of the scientific community, so that people will be motivated to join in the research.” Edwin Gale, an endocrinologist at the University of Bristol, UK, agreed with Butler, pointing out that “Pancreatitis may be just the tip of the iceberg, and it’s the iceberg that concerns me.”

Victoza Pancreatic Cancer Symptoms

In the early stages of the disease, a tumor in the pancreas may develop without any recognizable symptoms. For this reason, is often in its terminal stages when it is conclusively identified. Symptoms of pancreatic cancer may include:

  • dark urine
  • clay-colored stools
  • fatigue
  • weakness
  • jaundice
  • loss of appetite
  • weight loss
  • nausea
  • vomiting
  • pain or discomfort in the upper part of the belly or abdomen
  • back pain
  • blood clots
  • diarrhea
  • indigestion

Treatment

Treatment options for individuals with pancreatic cancer depend on the stage and location of the tumor(s), as well as the patient’s age, overall health and preferences. The primary goal of treatment is to destroy the tumors and eliminate the disease. When this isn’t possible, treatment becomes aimed at preventing the cancer from migrating to other areas of the body and causing more harm. In terminal stages where treatment is no longer effective, palliative care may be implemented to make the patient as comfortable as possible.

Click here to read more about Victoza pancreatic cancer from Bloomberg News.

Do I Have a Victoza Pancreatic Cancer Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Victoza lawsuits. We are handling individual litigation nationwide and currently accepting new pancreatic cancer cases in all 50 states.

Free Confidential Case Evaluation: Again, if you or a loved one has been diagnosed with pancreatic cancer after taking Victoza, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition